I couldn’t resist—here’s how ChatGPT ‘Ghiblized’ a famous photo of Emmanuelle Charpentier and Jennifer Doudna, Nobel Prize winners for the invention of CRISPR (with sincere apologies to Master Miyazaki).
CRISPR pioneers, Ghibli style
Reply
Tag Archives: Emmanuelle Charpentier
It takes two to think
Watson & Crick for the double helix. Doudna & Charpentier for CRISPR. Karikó & Weissman for RNA vaccines… Do two people think better than one or even many? Itai Yanai and Martin J. Lercher suggest so in Nature Biotechnology.
Continue readingThe latest twist in the battle to control CRISPR
Emmanuelle Charpentier and Jennifer Doudna won the Nobel Prize but not the intellectual property dispute and are now ready to give up two patents granted in Europe. The scoop once again comes from Antonio Regalado, who gained fame a few years ago for breaking the CRISPR babies scandal.
Continue readingA letter to Europe from CRISPR inventors and a thousand other scientists
Dear Members of the European Parliament,
In these times of climate crisis, biodiversity loss and renewed food insecurity, a scientific and evidence-based approach is essential in every respect. Now more than ever, we must rise above ideology and dogmatism. That is why we the undersigned turn to you and urge you to carefully consider the benefits of embracing New Genomic Techniques (NGTs) in your upcoming parliamentary decisions. As concerned citizens who believe in the power of science to improve our lives and our relationship with the planet, we implore you to vote in favour of NGTs, aligning your decisions with the advancements in scientific understanding. Conventional breeding for climate resilient crops (with cross-breeding of certain traits, subsequent selection and then backcrossing to remove undesirable traits) is too time-consuming. It takes years, decades even. We do not have this time in an era of climate emergency.
[Here you can read the full text of the letter and subscribe to it]
Festive feelings from CRISPeR Frenzy!
Emmanuelle Charpentier and Jennifer Doudna visiting the art work un|fold (Nobel Week Lights 2022, Stockholm). The sound and light sculpture is inspired by their research on genome editing.
Finally in Stockholm!
CRISPR inventors Emmanuelle Charpentier and Jennifer Doudna won the Nobel Prize in Chemistry in 2020, a pandemic year, so they had to wait until today, 10 December 2022, to experience the Nobel ceremony. Watch the video!
Nobel portraits, mind & hand
CRISPR inventors Emmanuelle Charpentier and Jennifer Doudna, portrayed by Herlinde Koelbl for the book Fascination of Science, which the photographer (famous for her work on Angela Merkel) dedicated to leading scientists. The photos, currently on display at the Koch Institute, capture “the connection between the personal & the pursuit of knowledge—between mind & hand—of pioneering scientists across the globe.”
CRISPR autograph collection!
A day with Emmanuelle Charpentier
Exa-cel, the first CRISPR therapy moves closer to market
The road from clinical trials to regulatory green light now appears to be downhill for the treatment for sickle cell anemia developed by CRISPR Therapeutics, the company co-founded by Emmanuelle Charpentier. We knew it as CTX001 but it has changed its name to exa-cel (which stands for exagamglogene autotemcel). It was one of the first CRISPR-based gene therapies to enter clinical trials, in 2019. It changed the lives of Victoria Gray and dozens of sickle cell anemia and thalassemia patients enrolled in several countries. Now it also leads the way in the late stage of the regulatory process, both in Europe and the United States, and could come to market first, in 2023. For more information see the press-release by Vertex, that collaborates at exa-cel manufacturing, regulatory and commercialization.
CRISPeR FRENZY 